Advertisement

The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors

Elias Jabbour, Hagop Kantarjian, Susan O'Brien, Jenny Shan, Alfonso Quintas-Cardama, Stefan Faderl, Guillermo Garcia-Manero, Farhad Ravandi, Mary Beth Rios and Jorge Cortes

Article Information

Citation 
vol. 118 no. 17 4541-4546
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted April 11, 2011
  • Accepted July 12, 2011
  • Published online October 27, 2011.

Article Versions


Contributors 
  • Elias Jabbour, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Hagop Kantarjian, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Susan O'Brien, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Jenny Shan, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Alfonso Quintas-Cardama, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Stefan Faderl, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Guillermo Garcia-Manero, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Farhad Ravandi, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Mary Beth Rios, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX
  • Jorge Cortes, 1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output